ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
2,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
2,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
4,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
5,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
6,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
6,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
7,1,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
8,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
8,2,Tachyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
8,3,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
9,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
9,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
10,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
11,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
11,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
13,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
14,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
15,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
15,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
16,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
17,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
18,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
19,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
20,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
21,1,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
22,1,Headache,Headaches NEC,Headaches,Nerv,N
23,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
23,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
23,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
25,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
25,2,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
25,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
25,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
25,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
25,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
26,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
27,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
27,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
27,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
27,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
28,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
28,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
29,1,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
30,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
31,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
31,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
32,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
32,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
33,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
33,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
34,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
35,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
35,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
35,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
35,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
36,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
36,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
37,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
38,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
39,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
39,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
39,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
39,4,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
39,5,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
39,6,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
39,7,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
39,8,Urethral disorder,Urethral disorders NEC,Urethral disorders (excl calculi),Renal,N
40,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
41,1,Female reproductive tract disorder,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
41,2,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
42,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
43,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
43,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
44,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
46,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
47,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
48,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
48,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
49,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
49,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
50,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
50,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
50,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
50,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
50,5,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
50,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
50,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
51,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
51,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
52,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
52,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
52,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,4,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
52,5,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
52,6,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
52,7,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
52,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
52,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
53,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,2,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
53,3,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
53,4,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
53,5,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
54,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
55,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
56,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
57,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
58,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
59,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
62,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
63,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
64,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
65,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
66,1,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
66,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
67,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
68,1,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
69,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
69,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
69,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
70,1,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
70,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
71,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
71,3,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
71,4,Vulvovaginal ulceration,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
72,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
72,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
72,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
73,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
73,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
74,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
74,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
75,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
75,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
76,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
76,2,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
77,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
78,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
78,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
79,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
80,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
80,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
81,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
82,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
82,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
83,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
83,2,Vulval ulceration,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
84,1,Acute motor-sensory axonal neuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
84,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
85,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
86,1,Acute motor-sensory axonal neuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
86,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
86,3,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
86,4,Vulvovaginal ulceration,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
87,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
87,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
87,3,Vulvovaginal ulceration,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
88,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
88,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
88,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
88,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
88,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
88,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
89,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
89,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
90,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
90,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
90,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
90,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
91,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
92,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
92,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
92,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
92,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,5,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
92,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
92,7,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
92,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
92,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
92,10,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
92,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
92,12,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
92,13,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
92,14,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
93,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
93,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
94,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
94,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
95,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
95,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
96,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
96,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
97,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
97,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
98,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
98,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
98,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
99,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
100,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
100,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
101,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
101,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
102,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
102,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
103,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
103,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
103,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
104,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
104,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
104,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
104,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
104,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
105,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
105,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
105,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
105,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
105,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
105,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
106,2,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
106,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
106,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
106,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
107,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
107,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
107,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
107,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
107,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
107,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
108,1,Haemorrhagic cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
108,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
108,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
108,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
108,5,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
108,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
109,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
109,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
109,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
109,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
109,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
110,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
110,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
111,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
111,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
111,3,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
111,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
111,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
111,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
111,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
112,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
112,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
112,3,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
113,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
114,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
114,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
114,3,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
114,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
114,5,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
114,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
114,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
114,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
115,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
115,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
115,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
116,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
116,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
116,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
117,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
117,2,Haemorrhagic cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
117,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
117,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
117,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
117,6,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
117,7,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
117,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
118,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
118,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
118,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
118,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
118,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
118,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
118,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
118,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
118,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
118,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
118,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
118,13,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
118,14,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
118,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
119,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
120,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
120,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
120,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
120,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
120,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
120,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
120,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
121,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
121,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
121,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
122,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
122,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
122,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
